Pennsylvania · Elmiron and claims for vision loss

Elmiron and claims for vision loss in Pennsylvania

See If You Qualify

Free · No obligation · About 2 minutes

Filing deadline2 years from discovery of Elmiron-related vision injuryPa. C.S. § 5524

Deadlines vary with the facts of each case. A lawyer can confirm yours.

Updated

01 · Your filing deadline

What is the deadline in Pennsylvania?

Pennsylvania Consolidated Statutes 42 Pa. C.S. § 5524 imposes a 2-year statute of limitations for personal injury claims including product liability. The discovery rule applies where the defect or its causal connection was not immediately discoverable — the clock starts when the plaintiff knew or should have known that Elmiron caused the vision damage. Pennsylvania does not have a statute of repose for pharmaceutical product liability claims. A lawyer can confirm yours.

2 years from discovery of Elmiron-related vision injury

Source: Pa. C.S. § 5524

Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.

Woman on the phone on her sofa, smiling
A lawyer can check which filing rules apply to your circumstances.

02 · Where cases are heard

Where would my case be heard?

Pennsylvania applies a 2-year statute of limitations for pharmaceutical product liability under 42 Pa. C.S. § 5524, with the discovery rule tolling the deadline for latent vision injuries. Pennsylvania does not have a statute of repose for pharmaceutical product liability. Philadelphia has historically been one of the most plaintiff-favorable pharmaceutical litigation venues in the country, and the state has a strong mass tort bar with extensive experience in drug injury cases.

Federal Elmiron cases from Pennsylvania are transferred to the MDL in the District of New Jersey (MDL No. 2973). Pennsylvania state court claims may proceed in Philadelphia County Court of Common Pleas, which has a dedicated mass tort program and has historically been among the most plaintiff-favorable pharmaceutical litigation venues in the nation. Pennsylvania applies a Frye standard for expert testimony in state courts. Pennsylvania's proximity to the D.N.J. MDL court and strong pharmaceutical litigation tradition make it a significant source of Elmiron claims.

How this works nationally

For the overall process and updates, read the Elmiron and claims for vision loss overview. This page covers the local information available for Pennsylvania.

What happens when I check?

You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.

Live in Pennsylvania? Read what applies in your state.

Register your interest. If a participating law firm takes these cases, it may contact you.

Register your interest

Sources

  1. Pa. C.S. § 5524